These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1507 related articles for article (PubMed ID: 28844808)

  • 1. The microbiota-gut-brain axis in obesity.
    Torres-Fuentes C; Schellekens H; Dinan TG; Cryan JF
    Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):747-756. PubMed ID: 28844808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and gut-microbiota-brain axis: A narrative review.
    Asadi A; Shadab Mehr N; Mohamadi MH; Shokri F; Heidary M; Sadeghifard N; Khoshnood S
    J Clin Lab Anal; 2022 May; 36(5):e24420. PubMed ID: 35421277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gut Microbiota: The Gateway to Improved Metabolism.
    Martinez KB; Pierre JF; Chang EB
    Gastroenterol Clin North Am; 2016 Dec; 45(4):601-614. PubMed ID: 27837775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut microbiota as a therapeutic target for obesity: a scoping review.
    Santos-Paulo S; Costello SP; Forster SC; Travis SP; Bryant RV
    Nutr Res Rev; 2022 Dec; 35(2):207-220. PubMed ID: 34100344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota and metabolic syndrome.
    Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
    World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet effects in gut microbiome and obesity.
    Chen J; He X; Huang J
    J Food Sci; 2014 Apr; 79(4):R442-51. PubMed ID: 24621052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota in Obesity and Undernutrition.
    de Clercq NC; Groen AK; Romijn JA; Nieuwdorp M
    Adv Nutr; 2016 Nov; 7(6):1080-1089. PubMed ID: 28140325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
    Amabebe E; Robert FO; Agbalalah T; Orubu ESF
    Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The critical role of gut microbiota in obesity.
    Cheng Z; Zhang L; Yang L; Chu H
    Front Endocrinol (Lausanne); 2022; 13():1025706. PubMed ID: 36339448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota-Gut-Brain Axis: Modulator of Host Metabolism and Appetite.
    van de Wouw M; Schellekens H; Dinan TG; Cryan JF
    J Nutr; 2017 May; 147(5):727-745. PubMed ID: 28356427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the role of the human gut microbiome in overweight and obesity.
    McBurney MI; Cho CE
    Ann N Y Acad Sci; 2024 Oct; 1540(1):61-88. PubMed ID: 39283061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiome approaches to treat obesity in humans.
    Bianchi F; Duque ALRF; Saad SMI; Sivieri K
    Appl Microbiol Biotechnol; 2019 Feb; 103(3):1081-1094. PubMed ID: 30554391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiomes in physiology: insights into 21st-century global medical challenges.
    Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
    Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromodulatory effect of microbiome on gut-brain axis; new target for obesity drugs.
    Ejtahed HS; Hasani-Ranjbar S
    J Diabetes Metab Disord; 2019 Jun; 18(1):263-265. PubMed ID: 31275897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota in obesity and metabolic disorders.
    Sanz Y; Santacruz A; Gauffin P
    Proc Nutr Soc; 2010 Aug; 69(3):434-41. PubMed ID: 20540826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.